EPM speaks to Gareth Bakewell, joint managing director at Reelvision about the evolution of packaging technologies in pharma and what this means for the safety of medicines.
Packaging in life sciences is constantly evolving with new safety features (anti-tampering, tracking technologies etc). Despite this, do you think these technologies are being implemented in enough of a widespread manner throughout the industry?
Without question there are many pharma companies that have a good strategy when it comes to protecting their products from targeted counterfeiters. These businesses have adopted a number of both physical and digital techniques. At Reelvision we have a constant flow of new designs and often receive artwork that contains various counterfeiting features ranging from micro dots that appear randomly to micro text with hidden copy errors and pattern gloss varnishes with intentional imperfections.